癌症2024，Vol.43Issue(8)：355-363,9.DOI:10.1200/JCO.22.01599
Ⅲ期KEYNOTE-006研究的7年随访:帕博利珠单抗与伊匹木单抗治疗晚期黑色素瘤的比较
Seven-Year Follow-Up of the Phase Ⅲ KEYNOTE-006 Study:Pembrolizumab Versus Ipilimumab in Advanced Melanoma
Caroline Robert 1Arnold Blaustein 2Michal Lotem 3Ana Arance 4Adil I Daud 5Omid Hamid 6James Larkin 7James Anderson 8Clemens Krepler 8Dmitri Grebennik 8Georgina V Long 9Matteo S Carlino 10丁娅 11张晓实 11Catriona McNeil 12Antoni Ribas 13Jean-JacquesGrob 14Jacob Schachter 15Marta Nyakas 16Damien Kee 17Teresa M Petrella18
作者信息
- 1. Gustave Roussy and Paris-Saclay University,Villejuif,France
- 2. Mount Sinai Medical Center Comprehensive Cancer Center,Miami Beach,FL
- 3. Sharett Institute of Oncology,Hadassah University Hospital Ein Kerem,Jerusalem,Israel
- 4. Hospital Clinic Barcelona and IDIBAPS,Barcelona,Spain
- 5. UCSF,San Francisco,CA
- 6. The Angeles Clinic and Research Institute,a Cedars-Sinai Affiliate,Los Angeles,CA
- 7. The Royal Marsden NHS Foundation Trust,London,United Kingdom
- 8. Merck& Co,Inc,Rahway,NJ
- 9. Melanoma Institute Australia,The University of Sydney,Royal North Shore and Mater Hospitals,Sydney,NSW,Australia
- 10. Melanoma Institute Australia,The University of Sydney,Westmead and Blacktown Hospitals,Sydney,NSW,Australia
- 11. 中山大学肿瘤防治中心生物治疗中心
- 12. Chris O'Brien Lifehouse,Camperdown,NSW,Australia
- 13. Jonsson Comprehensive Cancer Center at The University of California,Los Angeles(UCLA),Los Angeles,CA
- 14. Aix-Marseille University,Hospital of the Timone,Marseille,France
- 15. Sheba Medical Center-Tel HaShomer,Ramat Gan,Israel
- 16. Oslo University Hospital,Oslo,Norway
- 17. Austin Health,Heidelberg,VIC,Australia
- 18. Sunnybrook Health Sciences Centre,Toronto,ON,Canada
- 折叠
摘要
关键词
晚期黑色素瘤/帕博利珠单抗/伊匹木单抗/PD-1/PD-L1引用本文复制引用
Caroline Robert,Arnold Blaustein,Michal Lotem,Ana Arance,Adil I Daud,Omid Hamid,James Larkin,James Anderson,Clemens Krepler,Dmitri Grebennik,Georgina V Long,Matteo S Carlino,丁娅,张晓实,Catriona McNeil,Antoni Ribas,Jean-JacquesGrob,Jacob Schachter,Marta Nyakas,Damien Kee,Teresa M Petrella..Ⅲ期KEYNOTE-006研究的7年随访:帕博利珠单抗与伊匹木单抗治疗晚期黑色素瘤的比较[J].癌症,2024,43(8):355-363,9.
